Pharmacist

Master Class series about non-biological management of difficult to control asthma and beyond. 
Please complete the survey link at the bottom of the page to receive your CME certificate.

Master Class series about non-biological management of difficult to control asthma and beyond. 
Please complete the survey link at the bottom of the page to receive your CME certificate.

Master Class series about biological treatment options in Asthma and CRSwNP.
Please complete the survey link at the bottom of the page to receive your CME certificate.

On Wednesday, 20 April 2022 EUFOREA will celebrate the launch of the very first Global Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Awareness Day in Brussels.

Until now, patients with CRSwNP have had only limited opportunities for their voices to be heard, hence missing the opportunity to contribute to the improvement of CRSwNP care. In 2021, the Patient Advisory Board of EUFOREA published a statement that offered novel insights on the underestimated burden of CRSwNP and shortcomings of current care as well as multiple recommendations for action plans for implementation of better care for CRSwNP among all physicians treating patients with this disabling disease.

The aims of this campaign are:

to raise awareness of CRSwNP and comorbidities (asthma, atopic dermatitis, and its impact on quality of life among physicians, policymakers),

to encourage healthcare professionals at all levels to learn more about how they can improve outcomes for patients living with CRSwNP through improved diagnosis, treatment, and referrals to specialist care,

to educate patients on the symptoms of CRSwNP so that they can seek appropriate care in the management of their disease or to support loved ones suffering from CRSwNP and associated comorbidities including Asthma, Atopic Dermatitis (Eczema, and Allergy - respiratory or food allergy).

What is the impact of Chronic Rhinosinusitis on quality of life? Living with chronic rhinosinusitis can have an enormous impact on patients' quality of life. Many patients with chronic rhinosinusitis take multiple medication and have undergone multiple surgeries. In this video, a patient with chronic rhinosinusitis and asthma shares her story and explains how these diseases affect her day to day life and why there is a greater need for awareness of these conditions.

The background of this article focus on European patients with chronic rhinosinusitis with nasal polyps (CRSwNP) that have had only limited occasions to unite to have their voices heard, hence missing the opportunity to contribute to the improvement of CRSwNP care.

It aims to identify unmet needs in CRSwNP from the perspective of CRSwNP patients from the Patient Advisory Board (PAB) of the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA).

This statement of the EUFOREA Patient Advisory Board on CRSwNP provides novel insights on the underestimation of the burden of CRSwNP and shortcomings of current care. Multiple recommendations made by the patients can underpin action plans for the implementation of better care for CRSwNP among all physicians treating patients with this disabling disease.

View paper here